Gene · 2248
Papers2,103
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 2,103
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Au(I) Catalyzed HF Transfer: Tandem Alkyne Hydrofluorination and Perfluoroarene Functionalization. | ACS Catal | 2022 | 35433106 | PubTator, text mining | PubMed |
| Phosphine-catalyzed divergent domino processes between γ-substituted allenoates and carbonyl-activated alkenes. | Chem Sci | 2022 | 35414887 | PubTator, text mining | PubMed |
| Stereoselective 1,2-cis Furanosylations Catalyzed by Phenanthroline. | J Am Chem Soc | 2022 | 35413194 | PubTator, text mining | PubMed |
| Overview on Molecular Biomarkers for Laryngeal Cancer: Looking for New Answers to an Old Problem. | Cancers (Basel) | 2022 | 35406495 | PubTator, text mining | PubMed |
| Fibroblast Growth Factor Receptor 1-4 Genetic Aberrations as Clinically Relevant Biomarkers in Squamous Cell Lung Cancer. | Front Oncol | 2022 | 35402233 | PubTator, text mining | PubMed |
| EGFR-RAD51 gene fusion NSCLC responsiveness to different generation EGFR-TKIs: two cases and review of the literature. | Transl Lung Cancer Res | 2022 | 35399574 | PubTator, text mining | PubMed |
| Evaluation of Tumor DNA Sequencing Results in Patients with Gastric and Gastroesophageal Junction Adenocarcinoma Stratified by TP53 Mutation Status. | Oncologist | 2022 | 35380714 | PubTator, text mining | PubMed |
| EGFR Mutation and 11q13 Amplification Are Potential Predictive Biomarkers for Immunotherapy in Head and Neck Squamous Cell Carcinoma. | Front Immunol | 2022 | 35371031 | PubTator, text mining | PubMed |
| Otic Organoids Containing Spiral Ganglion Neuron-like Cells Derived from Human-induced Pluripotent Stem Cells as a Model of Drug-induced Neuropathy. | Stem Cells Transl Med | 2022 | 35356976 | PubTator, text mining | PubMed |
| Silver-catalyzed site-selective C(sp3)-H benzylation of ethers with N-triftosylhydrazones. | Nat Commun | 2022 | 35354822 | PubTator, text mining | PubMed |
| Roles of the fibroblast growth factor signal transduction system in tissue injury repair. | Burns Trauma | 2022 | 35350443 | PubTator, text mining | PubMed |
| Comprehensive Characterization of Human Lung Large Cell Carcinoma Identifies Transcriptomic Signatures with Potential Implications in Response to Immunotherapy. | J Clin Med | 2022 | 35329826 | PubTator, text mining | PubMed |
| The inherent flexibility of receptor binding domains in SARS-CoV-2 spike protein. | Elife | 2022 | 35323112 | PubTator, text mining | PubMed |
| Clinical significance of molecular subtypes of gastrointestinal tract adenocarcinoma. | World J Gastrointest Oncol | 2022 | 35321271 | PubTator, text mining | PubMed |
| Assessment of a cancer genomic profile test for patients with metastatic breast cancer. | Sci Rep | 2022 | 35315838 | PubTator, text mining | PubMed |
| iPSC-derived cranial neural crest-like cells can replicate dental pulp tissue with the aid of angiogenic hydrogel. | Bioact Mater | 2022 | 35310357 | PubTator, text mining | PubMed |
| A WIN Consortium phase I study exploring avelumab, palbociclib, and axitinib in advanced non-small cell lung cancer. | Cancer Med | 2022 | 35307972 | PubTator, text mining | PubMed |
| Toripalimab Plus Paclitaxel and Carboplatin as Neoadjuvant Therapy in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma. | Oncologist | 2022 | 35305102 | PubTator, text mining | PubMed |
| Molecular Characterization of KRAS Wild-type Tumors in Patients with Pancreatic Adenocarcinoma. | Clin Cancer Res | 2022 | 35302596 | PubTator, text mining | PubMed |
| Systemic and Intracranial Efficacy of Osimertinib in EGFR L747P-Mutant NSCLC: Case Report. | JTO Clin Res Rep | 2022 | 35295963 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2248/papers?page=24